Here we tested a DDX3X (DEAD box helicase) inhibitor (RK-33) [33–35] and three clinically established breast cancer chemotherapeutics: gemcitabine (GEM) [37], paclitaxel (PAC) [38], and doxorubicin (DOX) [36]. This evidence concerns the gene DDX3X and breast carcinoma.